Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population

NCT02420028 is registered in ClinicalTrials.gov with Optomeditech Oy as lead sponsor.

NCT NCT02420028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02420028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic Population
Lead sponsor
Optomeditech Oy
Phase
Not applicable
Overall status
Terminated
Start date
April 2, 2015
Completion date
August 5, 2016
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intravenous injections